USD 0.17
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -65.61 Thousand USD | 37.76% |
2022 | -105.41 Thousand USD | 18.96% |
2021 | -130.06 Thousand USD | -107.22% |
2020 | -62.77 Thousand USD | 28.74% |
2019 | -88.09 Thousand USD | -57.28% |
2018 | -56 Thousand USD | 15.24% |
2017 | -66.07 Thousand USD | 86.42% |
2016 | -486.45 Thousand USD | -23981.68% |
2015 | -2025.00 USD | 0.0% |
2013 | -18.16 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
2007 | -581.02 Thousand USD | 17.58% |
2006 | -711.03 Thousand USD | 28.81% |
2005 | -889.98 Thousand USD | -109.05% |
2004 | -439.49 Thousand USD | 2.69% |
2003 | -451.62 Thousand USD | 49.27% |
2002 | -890.34 Thousand USD | -231.58% |
2001 | -336.13 Thousand USD | 97.97% |
2000 | -13.2 Million USD | -838080.06% |
1999 | -1575.00 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 102.87 Thousand USD | 119.67% |
2023 Q2 | -57.92 Thousand USD | -365.59% |
2023 Q4 | 46.83 Thousand USD | 211.31% |
2023 Q1 | -12.44 Thousand USD | -21.37% |
2023 FY | - USD | 37.76% |
2023 Q3 | -42.07 Thousand USD | 27.37% |
2022 Q2 | -22.78 Thousand USD | 38.18% |
2022 Q1 | -36.85 Thousand USD | -14.19% |
2022 Q4 | -10.25 Thousand USD | 71.15% |
2022 FY | - USD | 18.96% |
2022 Q3 | -35.53 Thousand USD | -55.97% |
2021 FY | - USD | -107.22% |
2021 Q3 | -39.61 Thousand USD | -17.61% |
2021 Q2 | -33.68 Thousand USD | -37.47% |
2021 Q4 | -32.27 Thousand USD | 18.53% |
2021 Q1 | -24.5 Thousand USD | -81.21% |
2020 Q1 | -27.58 Thousand USD | -27.45% |
2020 Q3 | -11.87 Thousand USD | -21.25% |
2020 Q4 | -13.52 Thousand USD | -13.9% |
2020 FY | - USD | 28.74% |
2020 Q2 | -9790.00 USD | 64.5% |
2019 FY | - USD | -57.28% |
2019 Q1 | -28.33 Thousand USD | -59.88% |
2019 Q2 | -18.49 Thousand USD | 34.73% |
2019 Q4 | -21.64 Thousand USD | -10.24% |
2019 Q3 | -19.63 Thousand USD | -6.17% |
2018 Q1 | -3960.00 USD | 0.0% |
2018 Q2 | -6970.00 USD | -76.01% |
2018 Q4 | -17.72 Thousand USD | 35.21% |
2018 Q3 | -27.35 Thousand USD | -292.4% |
2018 FY | - USD | 15.24% |
2017 FY | - USD | 86.42% |
2016 FY | - USD | -23981.68% |
2015 FY | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2008 Q1 | -106.63 Thousand USD | 0.75% |
2008 Q3 | -115.57 Thousand USD | 5.2% |
2008 Q2 | -121.9 Thousand USD | -14.33% |
2007 Q3 | -131.44 Thousand USD | 11.23% |
2007 Q4 | -107.43 Thousand USD | 18.26% |
2007 FY | - USD | 17.58% |
2007 Q1 | -152.16 Thousand USD | 48.54% |
2007 Q2 | -148.07 Thousand USD | 2.69% |
2006 Q3 | -105.79 Thousand USD | 6.29% |
2006 FY | - USD | 28.81% |
2006 Q4 | -295.71 Thousand USD | -179.52% |
2006 Q2 | -112.89 Thousand USD | 16.78% |
2006 Q1 | -135.66 Thousand USD | 1.49% |
2005 Q4 | -137.72 Thousand USD | 26.22% |
2005 FY | - USD | -109.05% |
2005 Q3 | -186.65 Thousand USD | 59.09% |
2005 Q2 | -456.3 Thousand USD | -317.43% |
2005 Q1 | -109.31 Thousand USD | 10.71% |
2004 Q1 | -96.57 Thousand USD | 21.21% |
2004 FY | - USD | 2.69% |
2004 Q2 | -112.65 Thousand USD | -16.65% |
2004 Q3 | -90.39 Thousand USD | 19.76% |
2004 Q4 | -122.42 Thousand USD | -35.43% |
2003 Q4 | -122.57 Thousand USD | 9.09% |
2003 Q3 | -103.94 Thousand USD | -29.72% |
2003 Q2 | -103.94 Thousand USD | -15.12% |
2003 Q1 | -90.28 Thousand USD | 83.45% |
2003 FY | - USD | 49.27% |
2002 Q4 | -545.47 Thousand USD | -1659.6% |
2002 FY | - USD | -231.58% |
2002 Q3 | -31 Thousand USD | -102.51% |
2002 Q2 | -39.93 Thousand USD | 0.0% |
2001 FY | - USD | 97.97% |
2000 FY | - USD | -838080.06% |
1999 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Achiko AG | -8.32 Million USD | 99.212% |
Accelera Innovations, Inc | - USD | Infinity% |
Aspyra Inc. | -2.84 Million USD | 97.695% |
Cannabis Sativa, Inc. | -1.11 Million USD | 94.113% |
CompuMed, Inc. | 690.19 Thousand USD | 109.506% |
CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.031% |
Cogstate Limited | 9.89 Million USD | 100.663% |
CareView Communications, Inc. | -210.04 Thousand USD | 68.763% |
Craneware plc | 54.26 Million USD | 100.121% |
Caduceus Software Systems Corp. | -12.29 Million USD | 99.466% |
Certive Solutions Inc. | -704.66 Thousand USD | 90.689% |
Drug Free Solution, Inc. | -1.39 Million USD | 95.297% |
DATATRAK International, Inc. | 2.72 Million USD | 102.405% |
Healixa Inc. | -6.32 Million USD | 98.962% |
Easy Technologies Inc. | - USD | Infinity% |
eWellness Healthcare Corporation | - USD | Infinity% |
Founders Bay Holdings | 10.16 Million USD | 100.645% |
Health Discovery Corporation | - USD | Infinity% |
Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 84.58% |
H-Source Holdings Ltd. | - USD | Infinity% |
InterCare DX, Inc. | - USD | Infinity% |
IQ-AI Limited | -370.35 Thousand USD | 82.284% |
Cannabiz Mobile, Inc. | -750.00 USD | -8648.0% |
Mednow Inc. | -28.12 Million USD | 99.767% |
Galileo Life Sciences, Inc. | -270.72 Thousand USD | 75.765% |
MediXall Group, Inc. | -6.52 Million USD | 98.994% |
Mitesco, Inc. | -11.96 Million USD | 99.452% |
MobileSmith, Inc. | -13.83 Million USD | 99.526% |
NantHealth, Inc. | -38.53 Million USD | 99.83% |
Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 96.136% |
OneLife Technologies Corp. | - USD | Infinity% |
ORHub, Inc. | -12.08 Million USD | 99.457% |
Patient Access Solutions, Inc. | -12.09 Million USD | 99.458% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | 105.002% |
PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 187.796% |
Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -438.493% |
Renalytix Plc | -28.52 Million USD | 99.77% |
Revium Recovery Inc. | -678 Thousand USD | 90.323% |
RYAH Group, Inc. | - USD | Infinity% |
Carepay Inc. | -369.00 USD | -17680.488% |
Vaso Corporation | 4.19 Million USD | 101.564% |
Vynleads, Inc. | -235.72 Thousand USD | 72.167% |